References

1. Johannsen TH, Mallet D, Dige-Petersen H et al. Delayed Diagnosis of Congenital Adrenal Hyperplasia with Salt Wasting Due to Type II 3ß-Hydroxysteroid Dehydrogenase Deficiency. J ClinEndocrinol Metab. 2005; 90(4):2076-2080. PubMed | Google Scholar


2. Samara-Boustani D, Bachelot A, Pinto G et al.Blocs enzymatiques précoces de la surrénales. EMC (Elsevier Masson SAS, Paris), Endocrinologie-Nutrition, 10-015-B-20, 2008. Google Scholar


3. Bongiovanni AM. The adrenogenital syndrome with deficiency of 3ß- hydroxysteroid dehydrogenase. J Clin Invest. 1962; 41(11):2086-2092. PubMed | Google Scholar


4. Nordenström A, Forest MG, Wedell A. A Case of 3ß -Hydroxysteroid Dehydrogenase Type II (HSD3B2) deficiency picked up by neonatal screening for 21-Hydroxylase deficiency: Difficulties and Delay in Etiologic Diagnosis. Horm Res. 2007; 68(4):204-208. PubMed | Google Scholar


5. Codner E, OkumaC, Iniguez G et al. Molecular study of the 3ß -hydroxysteroid dehydrogenase gene type II in patients with hypospadias. J ClinEndocrinol Metab. 2004; 89(2):957-964. PubMed | Google Scholar


6. Moisan AM, Ricketts ML, Tardy V et al. New insight into the molecular basis of 3betahydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J ClinEndocrinolMetab. 1999; 84(12): 4410-25. PubMed | Google Scholar


7. Cara JF, Moshang T Jr, Bongiovanni AM et al. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3 ß -hydroxysteroid dehydrogenase deficiency. N Engl J Med. 1985; 313(1): 618-621. PubMed | Google Scholar


8. Rheaume E, Simard J, Morel Y et al. Congenital adrenal hyperplasia due to point mutations in the type II 3 ß -hydroxysteroid dehydrogenase gene. Nat Genet. 1992; 1(4):239-245. PubMed | Google Scholar


9. Marui S, Castro M, Latronico AC et al. Mutations in the type II 3 ß -hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. ClinEndocrinol (Oxf). 2000; 52(1): 67-75. PubMed | Google Scholar


10. Simard J, Ricketts ML, Gingras S et al. Molecular biology of the 3 hydroxysteroid dehydrogenase/5-4 isomerase gene family. Endocr Rev. 2005; 26(4):525-582. PubMed | Google Scholar


11. Pang S. Congenital adrenal hyperplasia owing to 3 ß -hydroxysteroid dehydrogenase deficiency. Endocrinol Metab Clin North Am. 2001; 30(1):81-99. PubMed | Google Scholar


12. Zachmann M, Vollmin JA, Murset G et al. Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-beta-hydroxysteroid dehydrogenase: Case report of a surviving girl and steroid studies. J Clin Endocrinol Metab. 1970; 30(6): 719-26. PubMed | Google Scholar


13. Rosenfield RL, Rich BH, Wolfsdorf JI et al. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980; 51(2): 345-53. PubMed | Google Scholar


14. Nayak S, Lee PA, Witchel SF. Variants of the type II 3betahydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. Mol Genet Metab. 1998; 64(3): 184- 92. PubMed | Google Scholar


15. Zachmann M, Forest MG, De Peretti E. 3 ß -Hydroxysteroid dehydrogenase deficiency: Follow-up study in a girl with pubertal bone age. Horm Res. 1979; 11(6):292-302. PubMed | Google Scholar


16. Alos N, Moisan AM, Ward L et al. AnovelA10E homozygous mutation in the HSD3B2gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty. J Clin Endocrinol Metab. 2000; 85(5): 1968-74. PubMed | Google Scholar